This was the stock's second consecutive day of losses.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth ...

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...

The Feb. 21 cyberattack on Change Healthcare crippled financial operations for hospitals, insurers, pharmacies and medical groups nationwide. In July, the organization began sending out breach ...